Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · Real-Time Price · USD

13.81

-0.68 (-4.69%)

At close: Feb 27, 2026, 4:00 PM EST

13.55

-0.26 (-1.88%)

After-hours: Feb 27, 2026, 7:56 PM EST

Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,341	2,454	1,861	301	715	675
Market Cap Growth	79.17%	31.88%	517.29%	-57.87%	6.05%	4.38%
Enterprise Value	6,824	5,081	4,434	2,989	3,372	3,471
Last Close Price	13.81	7.92	6.07	1.99	4.79	4.57
PE Ratio	735.82	-	-	-	67.35	7.41
Forward PE	14.70	11.69	11.92	2.71	5.65	7.07
PS Ratio	1.48	0.88	0.78	0.14	0.34	0.34
PB Ratio	-	-55.10	30.35	1.44	1.86	1.89
P/FCF Ratio	17.39	10.45	6.23	18.49	3.75	2.13
P/OCF Ratio	13.25	8.32	5.38	4.63	2.96	1.78
PEG Ratio	-	0.51	0.51	0.18	0.66	2.65
EV/Sales Ratio	2.32	1.82	1.85	1.35	1.61	1.74
EV/EBITDA Ratio	10.94	8.69	8.85	6.79	7.49	9.11
EV/EBIT Ratio	17.80	14.59	16.34	14.94	15.57	23.83
EV/FCF Ratio	27.34	21.64	14.84	183.29	17.67	10.94
Debt / Equity Ratio	-63.68	-58.22	44.87	13.62	7.52	8.41
Debt / EBITDA Ratio	4.17	4.28	5.26	6.15	6.15	7.36
Debt / FCF Ratio	10.76	11.05	9.21	174.50	15.13	9.46
Net Debt / Equity Ratio	-58.86	-55.70	43.34	13.49	6.87	7.45
Net Debt / EBITDA Ratio	3.98	4.24	5.31	6.40	5.86	6.97
Net Debt / FCF Ratio	9.94	10.57	8.89	172.79	13.82	8.37
Asset Turnover	0.83	0.80	0.66	0.57	0.53	0.52
Inventory Turnover	3.04	2.98	2.75	2.79	2.67	3.08
Quick Ratio	1.31	0.82	0.87	1.10	1.39	1.49
Current Ratio	2.13	1.41	1.63	1.88	2.25	2.29
Return on Equity (ROE)	-	-881.26%	-36.06%	-85.96%	5.45%	19.50%
Return on Assets (ROA)	6.79%	6.24%	4.67%	3.23%	3.41%	2.37%
Return on Invested Capital (ROIC)	13.13%	13.52%	9.45%	6.61%	4.62%	4.87%
Return on Capital Employed (ROCE)	14.00%	14.70%	10.30%	6.60%	6.60%	4.40%
Earnings Yield	0.14%	-4.76%	-4.51%	-43.12%	1.49%	13.50%
FCF Yield	5.75%	9.57%	16.06%	5.41%	26.68%	47.01%
Buyback Yield / Dilution	-9.44%	-75.42%	-16.69%	0.58%	-1.95%	-12.72%
Total Shareholder Return	-9.44%	-75.42%	-16.69%	0.58%	-1.95%	-12.72%

Updated Feb 27, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q